Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
Titel:
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
Auteur:
List, Alan F. Kopecky, Kenneth J. Willman, Cheryl L. Head, David R. Persons, Diane L. Slovak, Marilyn L. Dorr, Robert Karanes, Chatchada Hynes, Harry E. Doroshow, James H. Shurafa, Muhammad Appelbaum, Frederick R.